• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
73,319.55 185.23
( 0.25%)
Global Indices
Nasdaq
46,525.67 -61.07
(-0.13%)
Dow Jones
6,603.69 7.37
(0.11%)
Hang Seng
53,162.49 699.22
(1.33%)
Nikkei 225
10,436.29 71.50
(0.69%)
Forex
USD-INR
93.02 -0.15
(-0.16%)
EUR-INR
107.32 -0.65
(-0.60%)
GBP-INR
123.03 -0.78
(-0.63%)
JPY-INR
0.58 0.00
(-0.67%)

EQUITY - MARKET SCREENER

Caplin Point Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
524742
INE475E01026
242.5445604
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CAPLIPOINT
32.9
11917.49
EPS(TTM)
Face Value()
Div & Yield %
47.66
2
0.38
 

As on: Apr 02, 2026 12:00 AM

Last Price() Net Change (%) Volume (Nos) P / E
1,567.85 -5.85 7749 32.90
Stock Price Details
Open Price() 1,573.65
Best Buy () 0
Best Sell () 0
Buy Quantity (Nos) 0
Sell Quantity (Nos) 0
Today's High () 1,573.70
Today's Low () 1,510.00
52-Week High () 2396.95
152-Week Low () 1502.45
CHART
  • |
  • |
  • |
  • |
Market Statistics
Div & Yield % 0.38
Eps 47.66
Book Value 242.5445604
Market Cap (.Cr) 11,917.49
Face Value 2
Market Lot 1
AGM Date Sep
Book Closure Date Sep
ISIN No. INE475E01026


News
Caplin receives USFDA approval for Desmopressin Acetate Injection
Caplin Point’s arm Caplin Steriles gets USFDA nod for Sodium Phosphates Injection
Caplin Point Laboratories consolidated net profit rises 17.93% in the December 2025 quarter
Caplin Point Laboratories to announce Quarterly Result
Volumes spurt at Honasa Consumer Ltd counter
Caplin Point Laboratories consolidated net profit rises 18.08% in the September 2025 quarter
Caplin Point Laboratories standalone net profit declines 2.98% in the September 2025 quarter
Caplin Point Laboratories to hold board meeting
Caplin Point gets USFDA approval for Nicardipine Hydrochloride injection
Caplin Point Laboratories Ltd - Caplin Point Laboratories Limited - Press Release
More
Corporate Details
Incoporation Year   : 1990
Chairman : C C Paarthipan
Bussiness Group : Indian Private
Registered Office
Caplin Point Laboratories Ltd
Ashvich Towers 3rd Floor,
No 3 Developed Plots Ind Estat,
Chennai,
Tamil Nadu-600096
Cement House,
121 Maharshi Karve Road,
Mumbai,
Maharashtra-400020
Phone:91-44-24968000/71148000/28156653
Fax:91-44-28154952
Fax:91-22-66317458
E-Mail : investor@caplinpoint.net; info@caplinpoint.net
URL : http://www.caplinpoint.net


Exchange Information
Bombay Stock Exchange National Stock Exchange Other Listed Exchanges
  • BSE 500
  • BSE HC
  • BSE SmallCap
  • CNX 500
  • BSE
  • Kolkata
  • Chennai
  • Ahmedabad
  • Delhi
  • Kochi